nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—CYP1A2—Progesterone—uterine cancer	0.0998	0.303	CbGbCtD
Methotrimeprazine—CYP2D6—Progesterone—uterine cancer	0.0822	0.25	CbGbCtD
Methotrimeprazine—CYP2E1—Etoposide—uterine cancer	0.0772	0.235	CbGbCtD
Methotrimeprazine—CHRM3—ureter—uterine cancer	0.0646	0.179	CbGeAlD
Methotrimeprazine—CHRM3—muscle of abdomen—uterine cancer	0.0465	0.129	CbGeAlD
Methotrimeprazine—CYP1A2—Etoposide—uterine cancer	0.0447	0.136	CbGbCtD
Methotrimeprazine—Necrotising colitis—Epirubicin—uterine cancer	0.0344	0.116	CcSEcCtD
Methotrimeprazine—Necrotising colitis—Doxorubicin—uterine cancer	0.0318	0.107	CcSEcCtD
Methotrimeprazine—CYP2D6—Doxorubicin—uterine cancer	0.0251	0.0763	CbGbCtD
Methotrimeprazine—Drug interaction—Progesterone—uterine cancer	0.0149	0.0501	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Progesterone—uterine cancer	0.0138	0.0465	CcSEcCtD
Methotrimeprazine—Drug interaction—Medroxyprogesterone Acetate—uterine cancer	0.0135	0.0454	CcSEcCtD
Methotrimeprazine—CHRM3—exocrine gland—uterine cancer	0.0127	0.0352	CbGeAlD
Methotrimeprazine—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.0125	0.0422	CcSEcCtD
Methotrimeprazine—CHRM5—epithelium—uterine cancer	0.0099	0.0274	CbGeAlD
Methotrimeprazine—ADRA1D—epithelium—uterine cancer	0.00884	0.0245	CbGeAlD
Methotrimeprazine—HTR2A—artery—uterine cancer	0.00866	0.024	CbGeAlD
Methotrimeprazine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00865	0.0291	CcSEcCtD
Methotrimeprazine—ADRA1B—renal system—uterine cancer	0.00839	0.0232	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00831	0.0279	CcSEcCtD
Methotrimeprazine—DRD5—female reproductive system—uterine cancer	0.00819	0.0227	CbGeAlD
Methotrimeprazine—Weight increased—Progesterone—uterine cancer	0.0079	0.0266	CcSEcCtD
Methotrimeprazine—Drowsiness—Progesterone—uterine cancer	0.00774	0.026	CcSEcCtD
Methotrimeprazine—Jaundice—Progesterone—uterine cancer	0.00754	0.0254	CcSEcCtD
Methotrimeprazine—DRD5—female gonad—uterine cancer	0.00746	0.0206	CbGeAlD
Methotrimeprazine—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.00716	0.0241	CcSEcCtD
Methotrimeprazine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00701	0.0236	CcSEcCtD
Methotrimeprazine—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00684	0.023	CcSEcCtD
Methotrimeprazine—ADRA1D—female reproductive system—uterine cancer	0.00657	0.0182	CbGeAlD
Methotrimeprazine—ADRA2C—myometrium—uterine cancer	0.00617	0.0171	CbGeAlD
Methotrimeprazine—CHRM3—smooth muscle tissue—uterine cancer	0.00533	0.0148	CbGeAlD
Methotrimeprazine—CHRM3—renal system—uterine cancer	0.00513	0.0142	CbGeAlD
Methotrimeprazine—Agranulocytosis—Dactinomycin—uterine cancer	0.00511	0.0172	CcSEcCtD
Methotrimeprazine—ADRA1A—epithelium—uterine cancer	0.00508	0.0141	CbGeAlD
Methotrimeprazine—HRH1—myometrium—uterine cancer	0.00501	0.0139	CbGeAlD
Methotrimeprazine—ADRA2A—myometrium—uterine cancer	0.00492	0.0136	CbGeAlD
Methotrimeprazine—HTR2C—female reproductive system—uterine cancer	0.00486	0.0135	CbGeAlD
Methotrimeprazine—Tachycardia—Progesterone—uterine cancer	0.00482	0.0162	CcSEcCtD
Methotrimeprazine—ADRA2C—uterine cervix—uterine cancer	0.0048	0.0133	CbGeAlD
Methotrimeprazine—Liver injury—Epirubicin—uterine cancer	0.00471	0.0159	CcSEcCtD
Methotrimeprazine—ADRA1A—renal system—uterine cancer	0.00471	0.013	CbGeAlD
Methotrimeprazine—CHRM1—female reproductive system—uterine cancer	0.00459	0.0127	CbGeAlD
Methotrimeprazine—ADRA2C—decidua—uterine cancer	0.00457	0.0127	CbGeAlD
Methotrimeprazine—ADRA2C—renal system—uterine cancer	0.00449	0.0124	CbGeAlD
Methotrimeprazine—Somnolence—Progesterone—uterine cancer	0.00439	0.0148	CcSEcCtD
Methotrimeprazine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00437	0.0147	CcSEcCtD
Methotrimeprazine—Liver injury—Doxorubicin—uterine cancer	0.00436	0.0147	CcSEcCtD
Methotrimeprazine—ADRA2C—endometrium—uterine cancer	0.00434	0.012	CbGeAlD
Methotrimeprazine—Constipation—Progesterone—uterine cancer	0.00422	0.0142	CcSEcCtD
Methotrimeprazine—ADRA2C—mammalian vulva—uterine cancer	0.0042	0.0116	CbGeAlD
Methotrimeprazine—CHRM3—female reproductive system—uterine cancer	0.00411	0.0114	CbGeAlD
Methotrimeprazine—ADRA2C—uterus—uterine cancer	0.004	0.0111	CbGeAlD
Methotrimeprazine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00398	0.0134	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Epirubicin—uterine cancer	0.00397	0.0133	CcSEcCtD
Methotrimeprazine—HRH1—epithelium—uterine cancer	0.00393	0.0109	CbGeAlD
Methotrimeprazine—HRH1—uterine cervix—uterine cancer	0.0039	0.0108	CbGeAlD
Methotrimeprazine—CYP1A2—renal system—uterine cancer	0.0039	0.0108	CbGeAlD
Methotrimeprazine—Jaundice—Etoposide—uterine cancer	0.00386	0.013	CcSEcCtD
Methotrimeprazine—ADRA2A—uterine cervix—uterine cancer	0.00383	0.0106	CbGeAlD
Methotrimeprazine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00383	0.0129	CcSEcCtD
Methotrimeprazine—HRH1—smooth muscle tissue—uterine cancer	0.00379	0.0105	CbGeAlD
Methotrimeprazine—CHRM3—female gonad—uterine cancer	0.00374	0.0104	CbGeAlD
Methotrimeprazine—HRH1—decidua—uterine cancer	0.00371	0.0103	CbGeAlD
Methotrimeprazine—Agranulocytosis—Etoposide—uterine cancer	0.00369	0.0124	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Doxorubicin—uterine cancer	0.00367	0.0123	CcSEcCtD
Methotrimeprazine—ADRA2A—decidua—uterine cancer	0.00365	0.0101	CbGeAlD
Methotrimeprazine—Hypersensitivity—Progesterone—uterine cancer	0.00364	0.0122	CcSEcCtD
Methotrimeprazine—HRH1—endometrium—uterine cancer	0.00353	0.00976	CbGeAlD
Methotrimeprazine—CYP2E1—renal system—uterine cancer	0.0035	0.0097	CbGeAlD
Methotrimeprazine—ADRA2A—endometrium—uterine cancer	0.00346	0.00959	CbGeAlD
Methotrimeprazine—HRH1—mammalian vulva—uterine cancer	0.00341	0.00944	CbGeAlD
Methotrimeprazine—ADRA2A—mammalian vulva—uterine cancer	0.00335	0.00928	CbGeAlD
Methotrimeprazine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.0033	0.0111	CcSEcCtD
Methotrimeprazine—HTR2A—epithelium—uterine cancer	0.00328	0.00909	CbGeAlD
Methotrimeprazine—Photosensitivity—Epirubicin—uterine cancer	0.00328	0.011	CcSEcCtD
Methotrimeprazine—ADRA2C—female gonad—uterine cancer	0.00327	0.00906	CbGeAlD
Methotrimeprazine—ADRA2C—vagina—uterine cancer	0.00325	0.009	CbGeAlD
Methotrimeprazine—ADRA2A—uterus—uterine cancer	0.00319	0.00884	CbGeAlD
Methotrimeprazine—HTR2A—smooth muscle tissue—uterine cancer	0.00316	0.00876	CbGeAlD
Methotrimeprazine—HTR2A—renal system—uterine cancer	0.00305	0.00843	CbGeAlD
Methotrimeprazine—Photosensitivity—Doxorubicin—uterine cancer	0.00303	0.0102	CcSEcCtD
Methotrimeprazine—HRH1—female reproductive system—uterine cancer	0.00292	0.00809	CbGeAlD
Methotrimeprazine—ADRA2A—female reproductive system—uterine cancer	0.00287	0.00794	CbGeAlD
Methotrimeprazine—CYP2E1—female reproductive system—uterine cancer	0.00281	0.00777	CbGeAlD
Methotrimeprazine—CYP2D6—renal system—uterine cancer	0.00278	0.00768	CbGeAlD
Methotrimeprazine—HRH1—female gonad—uterine cancer	0.00266	0.00736	CbGeAlD
Methotrimeprazine—HRH1—vagina—uterine cancer	0.00264	0.00731	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Epirubicin—uterine cancer	0.00263	0.00884	CcSEcCtD
Methotrimeprazine—ADRA2A—female gonad—uterine cancer	0.00261	0.00723	CbGeAlD
Methotrimeprazine—ADRA2A—vagina—uterine cancer	0.00259	0.00718	CbGeAlD
Methotrimeprazine—Hypersensitivity—Dactinomycin—uterine cancer	0.00257	0.00864	CcSEcCtD
Methotrimeprazine—Tachycardia—Etoposide—uterine cancer	0.00246	0.00829	CcSEcCtD
Methotrimeprazine—HTR2A—female reproductive system—uterine cancer	0.00244	0.00675	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00243	0.00818	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Epirubicin—uterine cancer	0.00227	0.00764	CcSEcCtD
Methotrimeprazine—Weight increased—Epirubicin—uterine cancer	0.00227	0.00762	CcSEcCtD
Methotrimeprazine—Somnolence—Etoposide—uterine cancer	0.00224	0.00755	CcSEcCtD
Methotrimeprazine—CYP2D6—female reproductive system—uterine cancer	0.00222	0.00615	CbGeAlD
Methotrimeprazine—Drowsiness—Epirubicin—uterine cancer	0.00222	0.00746	CcSEcCtD
Methotrimeprazine—HTR2A—vagina—uterine cancer	0.00221	0.00611	CbGeAlD
Methotrimeprazine—Jaundice—Epirubicin—uterine cancer	0.00216	0.00727	CcSEcCtD
Methotrimeprazine—Constipation—Etoposide—uterine cancer	0.00216	0.00726	CcSEcCtD
Methotrimeprazine—ADRA2C—lymph node—uterine cancer	0.0021	0.00582	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.0021	0.00707	CcSEcCtD
Methotrimeprazine—Weight increased—Doxorubicin—uterine cancer	0.0021	0.00705	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Epirubicin—uterine cancer	0.00207	0.00696	CcSEcCtD
Methotrimeprazine—Drowsiness—Doxorubicin—uterine cancer	0.00205	0.0069	CcSEcCtD
Methotrimeprazine—CYP2D6—female gonad—uterine cancer	0.00202	0.0056	CbGeAlD
Methotrimeprazine—Jaundice—Doxorubicin—uterine cancer	0.002	0.00673	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Doxorubicin—uterine cancer	0.00192	0.00644	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Etoposide—uterine cancer	0.00186	0.00626	CcSEcCtD
Methotrimeprazine—HRH1—lymph node—uterine cancer	0.00171	0.00473	CbGeAlD
Methotrimeprazine—ADRA2A—lymph node—uterine cancer	0.00168	0.00465	CbGeAlD
Methotrimeprazine—Tachycardia—Epirubicin—uterine cancer	0.00138	0.00464	CcSEcCtD
Methotrimeprazine—Tachycardia—Doxorubicin—uterine cancer	0.00128	0.0043	CcSEcCtD
Methotrimeprazine—Somnolence—Epirubicin—uterine cancer	0.00126	0.00423	CcSEcCtD
Methotrimeprazine—Constipation—Epirubicin—uterine cancer	0.00121	0.00407	CcSEcCtD
Methotrimeprazine—Somnolence—Doxorubicin—uterine cancer	0.00116	0.00391	CcSEcCtD
Methotrimeprazine—Constipation—Doxorubicin—uterine cancer	0.00112	0.00377	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Epirubicin—uterine cancer	0.00104	0.00351	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Doxorubicin—uterine cancer	0.000965	0.00324	CcSEcCtD
Methotrimeprazine—HTR2C—GPCR downstream signaling—AKT1—uterine cancer	2.54e-06	0.000206	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CTNNB1—uterine cancer	2.53e-06	0.000205	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CXCL8—uterine cancer	2.52e-06	0.000204	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—HRAS—uterine cancer	2.5e-06	0.000203	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CDKN1B—uterine cancer	2.5e-06	0.000203	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—VEGFA—uterine cancer	2.5e-06	0.000202	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—PIK3CA—uterine cancer	2.5e-06	0.000202	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—AKT1—uterine cancer	2.47e-06	0.0002	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—NRAS—uterine cancer	2.47e-06	0.0002	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—VEGFA—uterine cancer	2.47e-06	0.0002	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—VEGFA—uterine cancer	2.47e-06	0.0002	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—PTEN—uterine cancer	2.47e-06	0.0002	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CDKN1B—uterine cancer	2.46e-06	0.000199	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—PIK3CA—uterine cancer	2.46e-06	0.000199	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—PIK3CA—uterine cancer	2.46e-06	0.000199	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—ERBB2—uterine cancer	2.45e-06	0.000198	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	2.45e-06	0.000198	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—PIK3CA—uterine cancer	2.44e-06	0.000198	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTEN—uterine cancer	2.44e-06	0.000197	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—NRAS—uterine cancer	2.44e-06	0.000197	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—NRAS—uterine cancer	2.44e-06	0.000197	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—AKT1—uterine cancer	2.44e-06	0.000197	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—PIK3CA—uterine cancer	2.44e-06	0.000197	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	2.43e-06	0.000197	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	2.43e-06	0.000197	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—ERBB2—uterine cancer	2.41e-06	0.000195	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—PIK3CA—uterine cancer	2.41e-06	0.000195	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—ERBB2—uterine cancer	2.41e-06	0.000195	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—AKT1—uterine cancer	2.41e-06	0.000195	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—PIK3CA—uterine cancer	2.4e-06	0.000195	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—AKT1—uterine cancer	2.4e-06	0.000194	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—ERBB2—uterine cancer	2.4e-06	0.000194	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—ERBB2—uterine cancer	2.39e-06	0.000194	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PTEN—uterine cancer	2.37e-06	0.000192	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—ERBB2—uterine cancer	2.37e-06	0.000192	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CTNNB1—uterine cancer	2.36e-06	0.000191	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	2.36e-06	0.000191	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—KRAS—uterine cancer	2.36e-06	0.000191	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—EP300—uterine cancer	2.35e-06	0.00019	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—KRAS—uterine cancer	2.33e-06	0.000189	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CTNNB1—uterine cancer	2.33e-06	0.000188	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—EP300—uterine cancer	2.33e-06	0.000188	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CXCL8—uterine cancer	2.32e-06	0.000188	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—AKT1—uterine cancer	2.31e-06	0.000187	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—HRAS—uterine cancer	2.31e-06	0.000187	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PTEN—uterine cancer	2.3e-06	0.000187	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CXCL8—uterine cancer	2.29e-06	0.000185	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CXCL8—uterine cancer	2.28e-06	0.000185	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CXCL8—uterine cancer	2.27e-06	0.000184	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—HRAS—uterine cancer	2.27e-06	0.000184	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CDKN1B—uterine cancer	2.27e-06	0.000184	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CXCL8—uterine cancer	2.27e-06	0.000184	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—HRAS—uterine cancer	2.27e-06	0.000184	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PTEN—uterine cancer	2.27e-06	0.000184	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—HRAS—uterine cancer	2.26e-06	0.000183	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—EP300—uterine cancer	2.26e-06	0.000183	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—HRAS—uterine cancer	2.25e-06	0.000182	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—AKT1—uterine cancer	2.25e-06	0.000182	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CXCL8—uterine cancer	2.25e-06	0.000182	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—AKT1—uterine cancer	2.25e-06	0.000182	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	2.24e-06	0.000181	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTEN—uterine cancer	2.24e-06	0.000181	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	2.23e-06	0.000181	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	2.23e-06	0.000181	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—HRAS—uterine cancer	2.23e-06	0.000181	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—KRAS—uterine cancer	2.23e-06	0.000181	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	2.23e-06	0.00018	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—VEGFA—uterine cancer	2.23e-06	0.00018	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	2.22e-06	0.00018	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CDKN1B—uterine cancer	2.22e-06	0.00018	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MTHFR—uterine cancer	2.22e-06	0.00018	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CDKN1B—uterine cancer	2.21e-06	0.000179	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—AKT1—uterine cancer	2.21e-06	0.000179	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	2.21e-06	0.000179	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	2.2e-06	0.000179	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NRAS—uterine cancer	2.2e-06	0.000178	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—AKT1—uterine cancer	2.2e-06	0.000178	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—EP300—uterine cancer	2.2e-06	0.000178	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	2.19e-06	0.000178	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CDKN1B—uterine cancer	2.19e-06	0.000178	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—AKT1—uterine cancer	2.19e-06	0.000177	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	2.19e-06	0.000177	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—PIK3CA—uterine cancer	2.17e-06	0.000176	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—AKT1—uterine cancer	2.17e-06	0.000176	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	2.16e-06	0.000175	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—EP300—uterine cancer	2.16e-06	0.000175	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CTNNB1—uterine cancer	2.14e-06	0.000174	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—PIK3CA—uterine cancer	2.14e-06	0.000173	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—VEGFA—uterine cancer	2.14e-06	0.000173	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—EP300—uterine cancer	2.13e-06	0.000173	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—KRAS—uterine cancer	2.13e-06	0.000172	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NRAS—uterine cancer	2.11e-06	0.000171	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	2.11e-06	0.000171	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	2.11e-06	0.000171	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CTNNB1—uterine cancer	2.1e-06	0.00017	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TP53—uterine cancer	2.1e-06	0.00017	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—KRAS—uterine cancer	2.1e-06	0.00017	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—KRAS—uterine cancer	2.1e-06	0.00017	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CTNNB1—uterine cancer	2.09e-06	0.000169	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PTEN—uterine cancer	2.09e-06	0.000169	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	2.08e-06	0.000169	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—VEGFA—uterine cancer	2.08e-06	0.000168	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	2.07e-06	0.000168	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—uterine cancer	2.07e-06	0.000168	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	2.07e-06	0.000167	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	2.07e-06	0.000167	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PTEN—uterine cancer	2.06e-06	0.000167	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NRAS—uterine cancer	2.06e-06	0.000166	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTEN—uterine cancer	2.05e-06	0.000166	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PTEN—uterine cancer	2.05e-06	0.000166	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—PIK3CA—uterine cancer	2.05e-06	0.000166	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	2.05e-06	0.000166	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PTEN—uterine cancer	2.05e-06	0.000166	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—AKT1—uterine cancer	2.04e-06	0.000165	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PTEN—uterine cancer	2.04e-06	0.000165	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	2.03e-06	0.000165	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NRAS—uterine cancer	2.02e-06	0.000164	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PTEN—uterine cancer	2.02e-06	0.000164	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PTEN—uterine cancer	2.01e-06	0.000163	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	2.01e-06	0.000163	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—HRAS—uterine cancer	2.01e-06	0.000163	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—AKT1—uterine cancer	2.01e-06	0.000162	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—AKT1—uterine cancer	2e-06	0.000162	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—AKT1—uterine cancer	2e-06	0.000162	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EP300—uterine cancer	1.99e-06	0.000161	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—AKT1—uterine cancer	1.99e-06	0.000161	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—uterine cancer	1.98e-06	0.000161	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—HRAS—uterine cancer	1.98e-06	0.00016	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—AKT1—uterine cancer	1.97e-06	0.00016	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	1.96e-06	0.000159	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EP300—uterine cancer	1.96e-06	0.000159	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—EP300—uterine cancer	1.96e-06	0.000159	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EP300—uterine cancer	1.96e-06	0.000158	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.96e-06	0.000158	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—PIK3CA—uterine cancer	1.95e-06	0.000158	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EP300—uterine cancer	1.95e-06	0.000158	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EP300—uterine cancer	1.94e-06	0.000157	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PIK3CA—uterine cancer	1.94e-06	0.000157	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—PIK3CA—uterine cancer	1.93e-06	0.000156	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—PIK3CA—uterine cancer	1.93e-06	0.000156	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EP300—uterine cancer	1.93e-06	0.000156	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EP300—uterine cancer	1.92e-06	0.000156	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	1.92e-06	0.000155	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—HRAS—uterine cancer	1.9e-06	0.000154	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—KRAS—uterine cancer	1.89e-06	0.000153	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—uterine cancer	1.89e-06	0.000153	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—VEGFA—uterine cancer	1.89e-06	0.000153	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PTEN—uterine cancer	1.87e-06	0.000152	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NRAS—uterine cancer	1.86e-06	0.000151	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—uterine cancer	1.86e-06	0.000151	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—uterine cancer	1.86e-06	0.000151	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—VEGFA—uterine cancer	1.86e-06	0.00015	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—VEGFA—uterine cancer	1.85e-06	0.00015	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—VEGFA—uterine cancer	1.85e-06	0.00015	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—VEGFA—uterine cancer	1.84e-06	0.000149	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NRAS—uterine cancer	1.83e-06	0.000149	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NRAS—uterine cancer	1.83e-06	0.000148	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	1.83e-06	0.000148	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NRAS—uterine cancer	1.83e-06	0.000148	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—VEGFA—uterine cancer	1.82e-06	0.000148	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NRAS—uterine cancer	1.82e-06	0.000147	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	1.82e-06	0.000147	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—KRAS—uterine cancer	1.82e-06	0.000147	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—HRAS—uterine cancer	1.81e-06	0.000146	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NRAS—uterine cancer	1.8e-06	0.000146	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NRAS—uterine cancer	1.8e-06	0.000145	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EP300—uterine cancer	1.78e-06	0.000145	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—HRAS—uterine cancer	1.78e-06	0.000144	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—HRAS—uterine cancer	1.78e-06	0.000144	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—AKT1—uterine cancer	1.77e-06	0.000144	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—KRAS—uterine cancer	1.77e-06	0.000143	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—AKT1—uterine cancer	1.75e-06	0.000142	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—KRAS—uterine cancer	1.74e-06	0.000141	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—PIK3CA—uterine cancer	1.74e-06	0.000141	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PIK3CA—uterine cancer	1.72e-06	0.000139	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	1.69e-06	0.000137	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—uterine cancer	1.68e-06	0.000136	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—AKT1—uterine cancer	1.67e-06	0.000136	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	1.67e-06	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NRAS—uterine cancer	1.67e-06	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PIK3CA—uterine cancer	1.63e-06	0.000132	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—uterine cancer	1.62e-06	0.000131	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—HRAS—uterine cancer	1.61e-06	0.00013	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—KRAS—uterine cancer	1.6e-06	0.00013	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	1.6e-06	0.00013	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—AKT1—uterine cancer	1.6e-06	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—AKT1—uterine cancer	1.59e-06	0.000129	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—KRAS—uterine cancer	1.58e-06	0.000128	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PIK3CA—uterine cancer	1.58e-06	0.000128	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—KRAS—uterine cancer	1.58e-06	0.000128	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—AKT1—uterine cancer	1.57e-06	0.000127	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—AKT1—uterine cancer	1.57e-06	0.000127	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—uterine cancer	1.57e-06	0.000127	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—KRAS—uterine cancer	1.57e-06	0.000127	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—KRAS—uterine cancer	1.57e-06	0.000127	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—KRAS—uterine cancer	1.55e-06	0.000126	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—uterine cancer	1.55e-06	0.000125	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—KRAS—uterine cancer	1.55e-06	0.000125	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—HRAS—uterine cancer	1.55e-06	0.000125	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—HRAS—uterine cancer	1.5e-06	0.000122	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—HRAS—uterine cancer	1.48e-06	0.00012	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PIK3CA—uterine cancer	1.47e-06	0.000119	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTEN—uterine cancer	1.46e-06	0.000118	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	1.45e-06	0.000117	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PIK3CA—uterine cancer	1.45e-06	0.000117	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	1.45e-06	0.000117	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PIK3CA—uterine cancer	1.44e-06	0.000117	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PIK3CA—uterine cancer	1.44e-06	0.000116	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—KRAS—uterine cancer	1.44e-06	0.000116	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—uterine cancer	1.43e-06	0.000116	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	1.42e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—AKT1—uterine cancer	1.42e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	1.42e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—AKT1—uterine cancer	1.41e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—uterine cancer	1.4e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—uterine cancer	1.4e-06	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—uterine cancer	1.4e-06	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—uterine cancer	1.39e-06	0.000113	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—EP300—uterine cancer	1.39e-06	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—uterine cancer	1.38e-06	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—uterine cancer	1.37e-06	0.000111	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—AKT1—uterine cancer	1.36e-06	0.000111	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—HRAS—uterine cancer	1.36e-06	0.00011	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—HRAS—uterine cancer	1.34e-06	0.000109	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—HRAS—uterine cancer	1.34e-06	0.000108	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—HRAS—uterine cancer	1.34e-06	0.000108	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—HRAS—uterine cancer	1.33e-06	0.000108	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—AKT1—uterine cancer	1.33e-06	0.000108	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	1.32e-06	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—HRAS—uterine cancer	1.32e-06	0.000107	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—HRAS—uterine cancer	1.31e-06	0.000106	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—AKT1—uterine cancer	1.31e-06	0.000106	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—AKT1—uterine cancer	1.29e-06	0.000104	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—uterine cancer	1.28e-06	0.000103	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTEN—uterine cancer	1.24e-06	0.0001	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HRAS—uterine cancer	1.22e-06	9.89e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AKT1—uterine cancer	1.2e-06	9.75e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AKT1—uterine cancer	1.19e-06	9.6e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—AKT1—uterine cancer	1.18e-06	9.59e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AKT1—uterine cancer	1.18e-06	9.58e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AKT1—uterine cancer	1.18e-06	9.55e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—EP300—uterine cancer	1.18e-06	9.54e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AKT1—uterine cancer	1.18e-06	9.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AKT1—uterine cancer	1.16e-06	9.42e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AKT1—uterine cancer	1.16e-06	9.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AKT1—uterine cancer	1.08e-06	8.73e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.03e-06	8.33e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CA—uterine cancer	8.71e-07	7.06e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AKT1—uterine cancer	8.4e-07	6.81e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AKT1—uterine cancer	7.12e-07	5.76e-05	CbGpPWpGaD
